Colgate Builds Sensitivity Offerings While Awaiting Pro-Relief Approval
This article was originally published in The Tan Sheet
Executive Summary
Colgate-Palmolive is bullish on driving oral care sales growth as it awaits FDA approval of its Colgate Sensitive Pro-Relief toothpaste with U.S. launches of three other toothpaste products.
You may also be interested in...
Colgate Bids To Expand U.S. Toothpaste Lineup Through FDA Rulemaking
Colgate seeks regulatory approval for a version of its Colgate Sensitive Multi-Protection toothpaste in a formulation it already markets internationally. The request made in a citizen petition comes after Colgate’s plan to expand its U.S. toothpaste business failed when FDA did not give approval for Sensitive Pro-Relief.